CytomX Therapeutics CTMX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$59.14M-241% | -$17.37M-162% | $28.02M-41.6% | $47.98M+15.3% | $41.6M+30.5% | ||
| $9M+42.8% | $6.3M-6.0% | $6.71M-8.3% | $7.32M-5.8% | $7.77M+1.3% | ||
| -$80.09M-6.0% | -$75.59M-4.6% | -$72.25M+6.7% | -$77.43M+4.7% | -$81.23M+5.8% | ||
| —— | —— | —— | $245K-22.0% | $314K+1.3% | ||
| -$283.56M-371% | -$60.18M-96.5% | -$30.63M-146% | -$12.46M-115% | $85.41M-14.3% | ||
| $344.93M+212% | $110.45M+15.0% | $96.05M+0.3% | $95.8M+1,204% | $7.35M-2.3% | ||
| -$18.28M+26.6% | -$24.89M— | —— | —— | —— | ||
| -$80.19M-5.8% | -$75.81M-4.8% | -$72.35M+6.9% | -$77.68M+4.7% | -$81.54M+5.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CytomX Therapeutics generate?
- CytomX Therapeutics (CTMX) generated -$80.1M in operating cash flow over the trailing twelve months.
- What is CytomX Therapeutics's free cash flow?
- After $347.0K of capital expenditures, CytomX Therapeutics's free cash flow was -$80.2M over the trailing twelve months, up 1.7% year over year.
- Where does CytomX Therapeutics's cash flow data come from?
- Every line is extracted from CytomX Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
